X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE PANACEA BIOTECH TTK HEALTHCARE/
PANACEA BIOTECH
 
P/E (TTM) x 29.1 84.6 34.3% View Chart
P/BV x 5.4 1.9 284.7% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 TTK HEALTHCARE   PANACEA BIOTECH
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
PANACEA BIOTECH
Mar-14
TTK HEALTHCARE/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs663149 446.1%   
Low Rs39982 484.8%   
Sales per share (Unadj.) Rs535.684.1 636.6%  
Earnings per share (Unadj.) Rs15.9-18.3 -87.1%  
Cash flow per share (Unadj.) Rs20.0-6.7 -298.9%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs137.683.7 164.4%  
Shares outstanding (eoy) m7.7761.25 12.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.4 72.2%   
Avg P/E ratio x33.3-6.3 -528.0%  
P/CF ratio (eoy) x26.5-17.2 -153.8%  
Price / Book Value ratio x3.91.4 279.8%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m4,1277,074 58.3%   
No. of employees `0001.72.8 62.1%   
Total wages/salary Rs m6071,449 41.9%   
Avg. sales/employee Rs Th2,436.71,874.1 130.0%   
Avg. wages/employee Rs Th355.2527.0 67.4%   
Avg. net profit/employee Rs Th72.5-407.7 -17.8%   
INCOME DATA
Net Sales Rs m4,1625,154 80.8%  
Other income Rs m61100 61.3%   
Total revenues Rs m4,2235,254 80.4%   
Gross profit Rs m197-766 -25.7%  
Depreciation Rs m32711 4.5%   
Interest Rs m301,503 2.0%   
Profit before tax Rs m197-2,881 -6.8%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m7317 433.3%   
Profit after tax Rs m124-1,121 -11.0%  
Gross profit margin %4.7-14.9 -31.9%  
Effective tax rate %37.0-0.6 -6,345.8%   
Net profit margin %3.0-21.8 -13.7%  
BALANCE SHEET DATA
Current assets Rs m1,6293,810 42.7%   
Current liabilities Rs m1,0588,365 12.6%   
Net working cap to sales %13.7-88.4 -15.5%  
Current ratio x1.50.5 338.0%  
Inventory Days Days30156 19.1%  
Debtors Days Days3467 50.0%  
Net fixed assets Rs m55614,480 3.8%   
Share capital Rs m7861 126.8%   
"Free" reserves Rs m878903 97.3%   
Net worth Rs m1,0695,127 20.9%   
Long term debt Rs m1595,832 2.7%   
Total assets Rs m2,39919,433 12.3%  
Interest coverage x7.6-0.9 -826.9%   
Debt to equity ratio x0.11.1 13.0%  
Sales to assets ratio x1.70.3 654.0%   
Return on assets %6.42.0 326.3%  
Return on equity %11.6-21.9 -53.0%  
Return on capital %18.53.6 507.5%  
Exports to sales %0.824.5 3.2%   
Imports to sales %1.410.2 13.8%   
Exports (fob) Rs m331,264 2.6%   
Imports (cif) Rs m58525 11.1%   
Fx inflow Rs m331,539 2.1%   
Fx outflow Rs m63942 6.7%   
Net fx Rs m-30597 -5.1%   
CASH FLOW
From Operations Rs m127599 21.1%  
From Investments Rs m-146-438 33.3%  
From Financial Activity Rs m22-303 -7.2%  
Net Cashflow Rs m3-141 -1.8%  

Share Holding

Indian Promoters % 65.4 74.5 87.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 0.6 616.7%  
FIIs % 5.2 1.3 400.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 23.6 109.3%  
Shareholders   12,723 10,259 124.0%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   STERLING BIOTECH  SANOFI INDIA  ALEMBIC PHARMA  MERCK LTD  NOVARTIS  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Aug 18, 2017 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS